SimVS logo — The Most Advanced Tablet-Based Clinical Simulation Platform

SimVS

The Most Advanced Tablet-Based Clinical Simulation Platform

United States Albany, United States 2 employees Health Care, Manufacturing +1

General Information

Company Name SimVS
Location United States Albany, United States +1
Employees 2
Industries Health Care, Manufacturing, Medical Devices
Social

Get notified when SimVS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SimVS

SimVS is a startup that offers an innovative clinical education platform, aiming to revolutionize traditional simulation systems. The company's slogan, "The Most Advanced Tablet-Based Clinical Simulation Platform," reflects its focus on technological advancement in healthcare education. SimVS utilizes tablets to provide a cost-effective solution for simulating realistic monitor operations across various patient conditions. The platform supports a wide range of monitors, including Hospital Monitor, Defibrillator, Mechanical Ventilator, Fetal Heart Monitor, Vital Signs numeric displays, Transport Ventilator, Telemetry Screen, Glucometer, Pulse Oximeter, Thermometer, and Nurse Call. SimVS operates within the Health Care, Manufacturing, and Medical Devices industries, highlighting its potential for widespread impact. As of now, there is no specific information available regarding the startup's founding date, headquarters, or previous investment details. These aspects are crucial in assessing the company's growth trajectory and financial backing. Despite the lack of publicly disclosed investment data, SimVS presents an intriguing proposition within the healthcare technology sector, with its innovative approach to clinical education and simulation. Given the growing demand for advanced medical training tools, SimVS appears to be well-positioned to attract potential investors seeking opportunities in healthcare technology. However, the lack of specific investment details presents a challenge in thoroughly evaluating the startup's financial standing and investor backing. Moving forward, **SimVS** would benefit from transparent communication regarding its founding, headquarters, and any previous or potential future investments to substantiate its growth potential and attract the interest of venture capital firms focused on healthcare innovation.

Taxonomy: Clinical Simulation, Medical Education, Patient Monitoring, Healthcare Simulation, Medical Training, Healthcare Devices, Simulation Platform, HealthTech, Healthcare Innovation

No funding data available for SimVS yet.

Get notified when SimVS raises funding

SimVS Alternatives & Competitors

SimVS vs

Revolutionizing medical training, worldwide.

Grant
4 employees
Manufacturing, Medical Devices
SimVS vs
IngMar Medical
IngMar Medical United States

Respiratory Simulation Specialists

29 employees
Health Care, Manufacturing
SimVS vs

Breathe Technologies, Inc. is a developer and manufacturer of innovative medical technologies for tr...

Series Unknown
26 employees
Health Care, Health and Wellness

FAQ About SimVS

The Most Advanced Tablet-Based Clinical Simulation Platform
SimVS is headquartered in Albany, United States.
SimVS operates in the following industries: Health Care, Manufacturing, Medical Devices.
SimVS has approximately 2 employees.
Top alternatives and competitors to SimVS include UpLeap (by breathe medical), IngMar Medical, Breathe Technologies, Inc., DeepMetrics, Endoclear. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SimVS and UpLeap (by breathe medical) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SimVS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy